Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue in septic shock
RBR-96584w4Phase 2Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methylene blue in septic shock and bloodstream infection (BSI) (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. Started Apr 2018; status: recruiting.
02
Drugs
methylene blue
03
Conditions
septic shockbloodstream infection (BSI)
Beyond the preview
Go deeper on RBR-96584w4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-96584w4.